Literature DB >> 8307263

Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells.

F Vollenweider1, J C Irminger, P A Halban.   

Abstract

Proinsulin is usually targetted to the regulated secretory pathway of beta cells, and converted to insulin in beta granules. Under certain pathological situations, a significant amount of proinsulin becomes diverted to the constitutive pathway. To study the kinetics of proinsulin conversion in the constitutive pathway, FAO (hepatoma) cells, which secrete proteins uniquely via this pathway and not the regulated pathway, were stably transfected with cDNA encoding human, rat I or rat II proinsulin. Products released to the medium of transfected cells were analysed by reversed phase HPLC and radioimmunoassay. For human proinsulin, des 31,32 split proinsulin (the conversion intermediate resulting from cleavage only at the B-chain/C-peptide junction followed by trimming of C-terminal basic residues by carboxypeptidase) was the only detectable conversion intermediate; for rat proinsulin II it was des 64,65 split proinsulin (cleaved and trimmed only at the C-peptide/A-chain junction); for rat proinsulin I, both intermediates were seen. Complete processing to insulin occurred for all three, but was most extensive for rat proinsulin I. When considered with the corresponding proinsulin sequences, these data show that a -4 basic residue (i.e. 4 residues N-terminal to the site of cleavage) facilitates proinsulin conversion in the constitutive pathway, and that arginine is preferred over lysine.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8307263     DOI: 10.1007/BF00400813

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  10 in total

1.  Processing of mutated proinsulin with tetrabasic cleavage sites to bioactive insulin in the non-endocrine cell line, COS-7.

Authors:  M Yanagita; K Nakayama; T Takeuchi
Journal:  FEBS Lett       Date:  1992-10-12       Impact factor: 4.124

2.  Sequence requirements for precursor cleavage within the constitutive secretory pathway.

Authors:  T Watanabe; T Nakagawa; J Ikemizu; M Nagahama; K Murakami; K Nakayama
Journal:  J Biol Chem       Date:  1992-04-25       Impact factor: 5.157

3.  Processing of proinsulin by transfected hepatoma (FAO) cells.

Authors:  F Vollenweider; J C Irminger; D J Gross; L Villa-Komaroff; P A Halban
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

Review 4.  Mammalian neural and endocrine pro-protein and pro-hormone convertases belonging to the subtilisin family of serine proteinases.

Authors:  N G Seidah; R Day; M Marcinkiewicz; S Benjannet; M Chrétien
Journal:  Enzyme       Date:  1991

5.  Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins.

Authors:  W J Sobey; S F Beer; C A Carrington; P M Clark; B H Frank; I P Gray; S D Luzio; D R Owens; A E Schneider; K Siddle
Journal:  Biochem J       Date:  1989-06-01       Impact factor: 3.857

6.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

7.  The processing of human proinsulin and chicken proalbumin by rat hepatic vesicles suggests a convertase specific for X-Y-Arg-Arg or Arg-X-Y-Arg sequences.

Authors:  S O Brennan; R J Peach
Journal:  J Biol Chem       Date:  1991-11-15       Impact factor: 5.157

8.  Arg-X-Lys/Arg-Arg motif as a signal for precursor cleavage catalyzed by furin within the constitutive secretory pathway.

Authors:  M Hosaka; M Nagahama; W S Kim; T Watanabe; K Hatsuzawa; J Ikemizu; K Murakami; K Nakayama
Journal:  J Biol Chem       Date:  1991-07-05       Impact factor: 5.157

Review 9.  Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1991-11       Impact factor: 10.122

10.  Newly synthesized proinsulin/insulin and stored insulin are released from pancreatic B cells predominantly via a regulated, rather than a constitutive, pathway.

Authors:  C J Rhodes; P A Halban
Journal:  J Cell Biol       Date:  1987-07       Impact factor: 10.539

  10 in total
  4 in total

1.  Processing of mutated human proinsulin to mature insulin in the non-endocrine cell line, CHO.

Authors:  S M Hunt; A S Tait; P P Gray; M J Sleigh
Journal:  Cytotechnology       Date:  1996       Impact factor: 2.058

2.  Chinese hamster ovary cells produce sufficient recombinant insulin-like growth factor I to support growth in serum-free medium. Serum-free growth of IGF-I-producing CHO cells.

Authors:  S M Hunt; S C Pak; M W Bridges; P P Gray; M J Sleigh
Journal:  Cytotechnology       Date:  1997-05       Impact factor: 2.058

Review 3.  Proinsulin processing in the regulated and the constitutive secretory pathway.

Authors:  P A Halban
Journal:  Diabetologia       Date:  1994-09       Impact factor: 10.122

Review 4.  Molecular mechanisms of transcription factor mediated cell reprogramming: conversion of liver to pancreas.

Authors:  Sebastian L Wild; David Tosh
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.